相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。eptic shock and community-acquired pneumonia associated with etanercept therapy
C. Nuñez-Cornejo et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Serious musculoskeletal infections in children receiving anti-tumor necrosis factor-α therapy: a case series
Kimberly Morishita et al.
CLINICAL RHEUMATOLOGY (2010)
A Woman with Respiratory Failure and a Cavitary Lesion in the Lung Invasive group A beta-hemolytic streptococcal infection, with acute necrotizing bronchopneumonia with cavitation and with evidence of the toxic shock syndrome, in a patient treated with anti-TNF antibody.
Michael E. Weinblatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis
Kyoung-Hwa Choi et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Fatal phenmococcal sepsis in patient with hicradenitis suppurative treated with inflixumeb
Juan Francisco Benitez-Macias et al.
MEDICINA CLINICA (2008)
Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Infliximab use in children and adolescents with inflammatory bowel disease
Lissy de Ridder et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
Jeffrey R. Curtis et al.
ARTHRITIS AND RHEUMATISM (2007)
Persistent periorbital and facial lymphedema associated with group A β-hemolytic streptococcal infection (erysipelas)
Golden T. Buckland et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2007)
Parapharyngeal abscess in a patient receiving etanercept
Joaquin Borras-Blasco et al.
ANNALS OF PHARMACOTHERAPY (2007)
Purpura fulminans in sepsis
Alex P. Betrosian et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2006)
Impact of biologic agents on infectious diseases
Lesley Ann Saketkoo et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2006)
Bacterial meningitis associated with infliximab
Raymond Farah et al.
PHARMACY WORLD & SCIENCE (2006)
Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
DJ Lovell et al.
ARTHRITIS AND RHEUMATISM (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Lethal acute respiratory distress syndrome during anti-TNF-α therapy for rheumatoid arthritis
C Zimmer et al.
CLINICAL RHEUMATOLOGY (2006)
Orbital cellulitis in a patient receiving infliximab for ankylosing spondylitis
JCP Roos et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis
A Mor et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2006)
Life threatening intra-abdominal sepsis in patients on anti-TNF-α therapy
S Goode et al.
GUT (2006)
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
MC Kapetanovic et al.
RHEUMATOLOGY (2006)
The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae
AC Kirby et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis
W Armbrust et al.
RHEUMATOLOGY (2004)
Fatal staphylococcal sepsis in Crohn's disease after infliximab
KR Herrlinger et al.
INFLAMMATORY BOWEL DISEASES (2004)
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor
AK Mohan et al.
CLINICAL INFECTIOUS DISEASES (2004)
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-α therapy
S Kroesen et al.
RHEUMATOLOGY (2003)
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis - Interim results from an ongoing multicenter, open-label, extended-treatment trial
DJ Lovell et al.
ARTHRITIS AND RHEUMATISM (2003)
Possible activation of an intramyocardial inflammatory process (Staphylococcus aureus) after treatment with infliximab in a boy with Crohn disease
P Reichardt et al.
EUROPEAN JOURNAL OF PEDIATRICS (2002)
Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis
ATY Chan et al.
POSTGRADUATE MEDICAL JOURNAL (2002)
Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease
MA Ritz et al.
INFLAMMATORY BOWEL DISEASES (2001)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Purpura fulminans caused by group a β-hemolytic Streptococcus sepsis
K Dhodapkar et al.
JOURNAL OF PEDIATRICS (2000)
Etanercept in children with polyarticular juvenile rheumatoid arthritis.
DJ Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Neck mass in a rheumatoid arthritis patient taking etanercept
JD Carter et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2000)
分享论文
